Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Ligand Pharmaceuticals Inc LGND

Healthcare
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LGND)

Ligand to Present at Stifel 2024 Healthcare Conference

Business Wire 9 days ago

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Business Wire November 7, 2024

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston

Business Wire November 1, 2024

Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024

Business Wire October 23, 2024

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

Business Wire September 6, 2024

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference

Business Wire August 20, 2024

Ligand Reports Second Quarter 2024 Financial Results

Business Wire August 6, 2024

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

Business Wire July 23, 2024

 Ligand to Acquire APEIRON Biologics AG for $100 Million

Business Wire July 8, 2024
View More News ››

Opinion & Analysis (NDAQ:LGND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LGND)

Buy Recommendation Issued On LGND By Craig-Hallum

Breaking News: $LGND Buy Recommendation Issued On LGND By Craig-Hallum2024-07-09 10:30:11 ET Craig-Hallum analyst issues BUY...
whytestocks - July 9, 2024

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising

BREAKING NEWS: $LGND Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising Moves in Tuesday SessionLigand Pharmaceuticals...
whytestocks - February 27, 2024

Next multibagger

https://stockhouse.com/news/press-releases/2019/01/31/patient-five-cancer-free-twelve-months-after-single-anti-cancer-treatment
goregil - February 14, 2019

Further Review

Although outside advisors recommended the approval of the drug to treat chronic ITP and the FDA was supposed to make a decision about it...
gossipgirl - June 20, 2008

RE: Chronic cure?

This a cure for generally the severe version, therefore at this moment its kind of lets worry about side affects later. Recently given...
amy89 - June 20, 2008

Chronic cure?

Promacta seems to be quite effective for short term use according to the FDA, but use of it to treat chronic conditions may have the side...
investology - June 12, 2008
View more Bullboard ››

Xcyte Digital Corp.

Xcyte Digital Corp.

Xcyte Digital is a virtual event company focused on simplifying the event hosting industry and expanding event hosting ...
View More »